<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107551</article-id><article-id pub-id-type="doi">10.7554/eLife.107551</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Rewiring the bone marrow: Evolution and the transcriptional architecture of trained immunity</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Sun</surname><given-names>Sarah J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5604-7324</contrib-id><email>sarahjiesun@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Aguirre-Gamboa</surname><given-names>Raúl</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2505-3574</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Barreiro</surname><given-names>Luis B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9456-367X</contrib-id><email>lbarreiro@uchicago.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>Committee on Immunology, University of Chicago</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>Medical Scientist Training Program, University of Chicago</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>Section of Genetic Medicine, Department of Medicine, University of Chicago</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>Department of Human Genetics, University of Chicago</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>Committee on Genetics, Genomics, and Systems Biology, University of Chicago</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/014nxkk19</institution-id><institution>Chan Zuckerberg Biohub Chicago Investigator</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Novakovic</surname><given-names>Boris</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048fyec77</institution-id><institution>Murdoch Children's Research Institute</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04fhee747</institution-id><institution>National Institute of Immunology</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>10</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e107551</elocation-id><history><date date-type="received" iso-8601-date="2025-05-13"><day>13</day><month>05</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-09-16"><day>16</day><month>09</month><year>2025</year></date></history><permissions><copyright-statement>© 2025, Sun et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Sun et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107551-v1.pdf"/><abstract><p>The epigenetic adaptation of innate immune cells to inflammatory stimuli, or trained immunity, represents an evolutionarily conserved feature of host defense. Recent advances have revealed that such adaptations can occur at the level of hematopoietic stem and progenitor cells, resulting in long-lasting epigenetic reprogramming of the immune system. However, a comprehensive mechanistic understanding of these processes remains incomplete, limiting our capacity to predict or therapeutically manipulate the adaptive capacity of hematopoiesis. In this review, we survey the current literature to support a model of hematopoietic memory whose stimulus-specific nuances are shaped by specific cytokine environments and driven by the combinatorial activity of key transcription factors. Comparative analyses underscore the evolutionary conservation and essential biological roles of these factors, suggesting that trained immunity may reflect the strategic repurposing of ancient transcriptional programs for the purpose of enhancing host defense.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>trained immunity</kwd><kwd>epigenetics</kwd><kwd>transcription factors</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043z4tv69</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI182148</award-id><principal-award-recipient><name><surname>Barreiro</surname><given-names>Luis B</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043z4tv69</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI190301</award-id><principal-award-recipient><name><surname>Barreiro</surname><given-names>Luis B</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q48ey07</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM152227</award-id><principal-award-recipient><name><surname>Barreiro</surname><given-names>Luis B</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q48ey07</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM150375</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Sarah J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>University of Chicago</institution></institution-wrap></funding-source><award-id>T32GM150375</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Sarah J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>University of Chicago</institution></institution-wrap></funding-source><award-id>NIDDK P30 DK042086</award-id><principal-award-recipient><name><surname>Barreiro</surname><given-names>Luis B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The innate immune system is the oldest branch of the broader human immune system and the sole source of immunity in most living species, including plants and invertebrates (<xref ref-type="bibr" rid="bib39">Pancer and Cooper, 2006</xref>). In humans, quintessential innate immune cells, such as macrophages and dendritic cells (DCs), detect and ultimately eliminate pathogens via the expression of fixed, germline-encoded pathogen recognition receptors (PRRs), which confer innate immune cells with the ability to broadly recognize and phagocytose pathogenic microorganisms while preserving self-tolerance. Adaptive immune cells, such as T-cells, are more complex. They recombine germline-encoded sequences to generate an essentially infinite number of unique receptors with exquisite specificity. T-cells also exist in different states, such as ‘naïve’, ‘effector’, and ‘memory’, and the activation of a naïve cell by its specific antigen induces the permanent differentiation of the T-cell clone into a memory state via the induction of complex transcriptional, metabolic, and epigenetic remodeling.</p><p>Traditionally, this capacity for durable, antigen-specific memory was considered exclusive to the adaptive immune system. However, the field has evolved to appreciate the spectrum-like nature of memory (when loosely defined as short or long-term changes in immune cells that result from transient stimuli). All immune cells exhibit some ability to adapt, but the duration and specificity of these adaptations vary. Certain innate-like lymphocytes—including invariant natural killer T cells, mucosal-associated invariant T cells, and γδ T-cells—exhibit memory-like features despite utilizing a limited range of antigen receptors (<xref ref-type="bibr" rid="bib43">Pellicci et al., 2020</xref>), blurring the classical boundaries between innate and adaptive immunity and highlighting the role of multiple types of memory in the immune response.</p><p>The expanding view of immune memory stems largely from discoveries made in the late 2000s and early 2010s, which revealed that classical innate immune cells can undergo short-term epigenetic, metabolic, and transcriptional reprogramming—typically lasting around 7 days—following PRR stimulation (<xref ref-type="bibr" rid="bib6">Cheng et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Foster et al., 2007</xref>; <xref ref-type="bibr" rid="bib46">Quintin et al., 2012</xref>). These changes, in some cases, led to heightened inflammatory responses upon subsequent, nonspecific challenges (<xref ref-type="bibr" rid="bib6">Cheng et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Quintin et al., 2012</xref>). The term ‘trained immunity’ was coined in 2011 (<xref ref-type="bibr" rid="bib32">Netea et al., 2011</xref>) to describe this phenomenon, which had long been observed in plants and invertebrates (<xref ref-type="bibr" rid="bib16">Gourbal et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Netea et al., 2019</xref>). Organisms as primitive as bacteria exhibit memory-like immunity through the CRISPR-Cas system, which incorporates viral DNA fragments into their genome to ‘remember’ and target future infections (<xref ref-type="bibr" rid="bib16">Gourbal et al., 2018</xref>). In plants, a system called systemic acquired resistance enables adaptation to pathogens through epigenetic and transcriptional mechanisms (<xref ref-type="bibr" rid="bib16">Gourbal et al., 2018</xref>). Evidence of innate immune memory has also been reported in organisms, such as mosquitoes and copepods, both of which rely exclusively on innate immunity (<xref ref-type="bibr" rid="bib16">Gourbal et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Netea et al., 2019</xref>). That such innate memory also existed within vertebrates was subsequently more formally demonstrated in human monocytes stimulated ex vivo with β-glucan (<xref ref-type="bibr" rid="bib6">Cheng et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Quintin et al., 2012</xref>) and shown to have an epigenetic and metabolic basis. These findings supported a broader plasticity across the immune system and, thus, a more complex evolutionary model in which the capacity for epigenetic adaptation to environmental stimuli is a basic feature of all immune cells across species, while the evolution of antigen-specific receptors marks a key innovation of adaptive immunity in vertebrates (<xref ref-type="bibr" rid="bib16">Gourbal et al., 2018</xref>).</p><p>While in vitro studies provided evidence that short-lived innate immune cells could acquire nonspecific memory, their limited lifespan raised questions about the durability of such responses. This led to the hypothesis that long-term innate immune memory must be encoded in long-lived cell populations, such as tissue-resident innate cells and/or hematopoietic stem and progenitor cells (HSPCs). In 2018, several pivotal studies confirmed this hypothesis, showing that HSPCs can undergo persistent epigenetic, metabolic, and transcriptional reprogramming in response to inflammatory stimuli. These rewired HSPCs are capable of harboring molecular signatures of memory long-term through their ability to self-renew and are thought to continuously give rise to monocytes and neutrophils with enhanced innate immune responsiveness (<xref ref-type="bibr" rid="bib8">Christ et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Mitroulis et al., 2018</xref>). This introduced a new conceptual framework: short-term, peripheral trained immunity (within mature innate immune cells) vs. a more long-term hematopoietic reprogramming wherein molecular adaptations encoded in long-lived stem and progenitor cells can be passed on to their mature immune progeny. Such progeny, in turn, often appear to harbor the classical characteristics of peripherally trained cells (<xref ref-type="bibr" rid="bib35">Netea et al., 2020</xref>) and are capable of establishing long-term residence within inflamed tissues, further contributing to the longevity of innate immune memory (<xref ref-type="bibr" rid="bib42">Patel et al., 2021</xref>). Together with a growing body of evidence that long-lived, self-renewing yolk-sac-derived tissue resident macrophages can harbor epigenetic memory of infections (<xref ref-type="bibr" rid="bib42">Patel et al., 2021</xref>), the influx of reprogrammed bone-marrow-derived macrophages into inflamed tissues serves to fundamentally rewire innate immune responses within those tissues. This phenomenon is sometimes referred to as ‘central trained immunity’, although in this review, we will use the looser term of <italic>hematopoietic reprogramming</italic> to broaden our discussion to studies that, in our view, do not meet strict criteria for central trained immunity (see below for a more extensive discussion about terminology).</p><p>Extensive reviews have covered the triggers and mechanisms underlying peripheral trained immunity (<xref ref-type="bibr" rid="bib2">Bekkering et al., 2018</xref>; <xref ref-type="bibr" rid="bib5">Chavakis et al., 2022</xref>; <xref ref-type="bibr" rid="bib11">Divangahi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Netea et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Vuscan et al., 2024</xref>), as well as the growing body of work surrounding central trained immunity (<xref ref-type="bibr" rid="bib5">Chavakis et al., 2022</xref>; <xref ref-type="bibr" rid="bib4">Chavakis et al., 2019</xref>; <xref ref-type="bibr" rid="bib11">Divangahi et al., 2021</xref>). However, a unified framework capable of explaining and predicting hematopoietic reprogramming across different contexts remains elusive. In this review, we aim to contribute to this ongoing discussion by focusing on memory within the hematopoietic system. In the first section, we adopt a mechanistic perspective to explore how specific stimuli can durably rewire hematopoiesis, altering innate immune output and function—emphasizing the roles of cytokine signaling and the activation of pioneering transcription factors (TFs). In the second section, we take a broader evolutionary and comparative view, highlighting the deep conservation of transcriptional machinery across species. We also explore emerging evidence of species-specific differences in hematopoietic memory mechanisms, particularly between mice and humans, and consider how these insights might guide future research in the field.</p></sec><sec id="s2"><title>Terminology: hematopoietic reprogramming</title><p>The term ‘(peripheral) trained immunity’, since first being coined in 2011, has classically been used to refer to the ability of a primary stimulus to directly reprogram innate immune cells to mount <italic>stronger</italic> cytokine responses to diverse secondary stimuli as compared to their naïve counterparts (<xref ref-type="bibr" rid="bib32">Netea et al., 2011</xref>). This definition highlights the difference between trained immunity and the related phenomenon of innate immune tolerance in which strong lipopolysaccharide (LPS) stimulation leads to a temporary state of innate immune hypo<italic>-</italic>responsiveness to secondary stimulation (<xref ref-type="bibr" rid="bib13">Foster et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Novakovic et al., 2016</xref>). Another requirement is that cells return to a transcriptional baseline in between primary and secondary stimuli, retaining only epigenetic signatures imprinted by the primary stimulus to keep the chromatin in a more accessible, ‘ready’, state (<xref ref-type="bibr" rid="bib11">Divangahi et al., 2021</xref>). Failure to return to a transcriptional baseline in between the primary and secondary stimulus has in some of the literature been termed ‘priming’ to distinguish it from the more strict definition of ‘training’ (<xref ref-type="bibr" rid="bib29">Mishra and Ivashkiv, 2024</xref>).</p><p>Defining trained immunity of the hematopoietic system has proven to be more complex. While stimulus-induced changes within HSPCs do often lead to the production of innate immune cells which appear classically ‘trained’, the HSPCs themselves, from which these innate cells are derived, often retain residual changes in gene expression, TF activity, cell abundances, and lineage biases, even long after presumed clearance of the initiating stimulus. Relying on in vivo systems, it then also becomes difficult to determine whether residual inflammation from the primary stimulus may exist, or whether the residual changes in HSPCs represent a true, independent, rewiring of their transcriptional circuitry. Not surprisingly, existing studies have often used diverse indices of what it means for the bone marrow to be ‘trained’. Although the studies and examples discussed in this review have been categorized as examples of central trained immunity, we will from here on use the broader term <italic>hematopoietic reprogramming</italic> to acknowledge the fact that not all studies meet the definition of trained immunity in its strictest sense. <italic>Hematopoietic reprogramming</italic> (as a substitute for <italic>central trained immunity</italic>) will be used here to refer to long-lasting changes (this may include any combination of epigenetic, transcriptional, metabolic, or other persistent alterations) in HSPCs persisting in the absence of detectable levels of the primary stimulus, and leading to enhanced downstream innate immune cell function, composition, or responses to secondary stimuli.</p></sec><sec id="s3"><title>Cytokine-induced EM is integral to the establishment of hematopoietic reprogramming</title><p>Emergency myelopoiesis (EM) is believed to be an essential component of hematopoietic reprogramming. In general terms, it is defined as a reactive homeostatic response of HSPCs to increased myeloid cell demand (<xref ref-type="bibr" rid="bib28">Manz and Boettcher, 2014</xref>). EM is therefore a central feature of systemic bacterial infections (<xref ref-type="bibr" rid="bib28">Manz and Boettcher, 2014</xref>), and viral infections, such as COVID-19 (<xref ref-type="bibr" rid="bib47">Schulte-Schrepping et al., 2020</xref>), which induce widespread inflammation and the depletion of neutrophils as they infiltrate into tissues. Noninfectious, iatrogenic causes such as myeloablative chemotherapy can also act as triggers of HSC proliferation and myeloid cell regeneration (<xref ref-type="bibr" rid="bib45">Pietras et al., 2016</xref>), demonstrating that the mere act of myeloid cell depletion in the absence of infection is sufficient to drive this response. Mechanistically, peripheral signals of myeloid cell demand cause usually dormant, pluripotent long-term HSCs (LT-HSCs) to expand and give rise to myeloid-biased multipotent progenitors (MPPs). EM also involves the entry of normally quiescent lineage-committed granulocyte-monocyte precursors (GMPs) into the cell cycle (<xref ref-type="bibr" rid="bib50">Swann et al., 2024</xref>). These events are largely thought to be coordinated by the action of key cytokines, including G-CSF, GM-CSF, M-CSF, IL6, IL-1β, TNFα, TGFβ, and type I and type II interferons (<xref ref-type="bibr" rid="bib28">Manz and Boettcher, 2014</xref>; <xref ref-type="bibr" rid="bib40">Park et al., 2024</xref>; <xref ref-type="bibr" rid="bib41">Pascutti et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Swann et al., 2024</xref>), although other cytokines, including IL4, have also been shown to coordinate EM under certain circumstances (<xref ref-type="bibr" rid="bib22">LaMarche et al., 2024</xref>). Signaling by cytokines, either in combination or in isolation, results in cell proliferation at multiple points in the hematopoietic hierarchy, as well as the activation of lineage-determining TFs such as PU.1 (<xref ref-type="bibr" rid="bib17">Heinz et al., 2010</xref>) and CEBPβ (<xref ref-type="bibr" rid="bib18">Hirai et al., 2006</xref>), which bias stem cells toward the myeloid lineage (<xref ref-type="bibr" rid="bib10">de Laval et al., 2020</xref>; <xref ref-type="bibr" rid="bib45">Pietras et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Yamashita and Passegué, 2019</xref>).</p><p>We believe that these processes, usually perceived as transient changes enabling the temporary mobilization of monocytes and granulocytes in times of need, are essential in the induction of persistent hematopoietic reprogramming and that cytokine-induced EM serves as a necessary, but likely not sufficient, trigger of hematopoietic reprogramming. In support of this hypothesis, our review of the literature (see examples below) has consistently demonstrated that an initial EM response precedes hematopoietic reprogramming. Most stimuli lead to the upregulation of at least one identifiable cytokine among IL1β, IFNγ, or IL6 (<xref ref-type="bibr" rid="bib5">Chavakis et al., 2022</xref>; <xref ref-type="bibr" rid="bib4">Chavakis et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Zhao et al., 2014</xref>)—one possible exception being LPS which may directly act on HSCs via Toll-like receptor signaling (<xref ref-type="bibr" rid="bib4">Chavakis et al., 2019</xref>; <xref ref-type="bibr" rid="bib10">de Laval et al., 2020</xref>). Even so, TLR ligation is believed to lead to the production of cytokines such as IL6, which feedback to partially instruct EM via paracrine signaling (<xref ref-type="bibr" rid="bib4">Chavakis et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Zhao et al., 2014</xref>). In general, we find that differences in hematopoietic reprogramming between stimuli can be, to some extent, predicted by the cytokines they produce (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Cytokine-induced hematopoietic reprogramming.</title><p>The table includes stimuli of hematopoietic reprogramming from studies for which cytokines were directly investigated. The phenotype-defining cytokine is bolded. Rows are colored according to cytokine (red—IL1β, yellow—IL6 ± IFN, blue—IFN in the absence of IL6). Stimuli that induce similar cytokine repertoires also produce similar reprogramming effects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Stimulus</th><th align="left" valign="top">Species studied</th><th align="left" valign="top">Type</th><th align="left" valign="top">Key cytokines induced</th><th align="left" valign="top">Persistent reprogramming outcome</th><th align="left" valign="top">References</th></tr></thead><tbody><tr><td style="background-color: #E57373;">β-Glucan</td><td style="background-color: #E57373;">Mice</td><td style="background-color: #E57373;">Infectious mimic (PRR agonist) and inflammasome activator</td><td style="background-color: #E57373;"><bold>IL-1β,</bold> G-CSF</td><td style="background-color: #E57373;">Inherent LT-HSC myeloid bias; trained EM response to chemotherapy</td><td style="background-color: #E57373;"><xref ref-type="bibr" rid="bib30">Mitroulis et al., 2018</xref></td></tr><tr><td style="background-color: #E57373;">LIP</td><td style="background-color: #E57373;">Mice</td><td style="background-color: #E57373;">Sterile inflammation</td><td style="background-color: #E57373;"><bold>IL-1β</bold>, G-CSF</td><td style="background-color: #E57373;">Inherent LT-HSC myeloid bias; trained EM response to LPS;<break/>primed monocyte and neutrophil TNFα/IL-6 secretion upon LPS challenge</td><td style="background-color: #E57373;"><xref ref-type="bibr" rid="bib26">Li et al., 2022</xref></td></tr><tr><td style="background-color: #90CAF9;">BCG vaccination</td><td style="background-color: #90CAF9;">Mice</td><td style="background-color: #90CAF9;">Live attenuated infection</td><td style="background-color: #90CAF9;"><bold>IFN-γ</bold></td><td style="background-color: #90CAF9;">Increased macrophage antimicrobial activity; IFN-γ dependent</td><td style="background-color: #90CAF9;"><xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref></td></tr><tr><td style="background-color: #FFF176;">COVID-19 infection</td><td style="background-color: #FFF176;">Human</td><td style="background-color: #FFF176;">Viral infection</td><td style="background-color: #FFF176;"><bold>IL-6</bold></td><td style="background-color: #FFF176;">Lasting monocyte chromatin remodeling and priming; persistent GMP expansion; reversed by IL-6 blockade</td><td style="background-color: #FFF176;"><xref ref-type="bibr" rid="bib7">Cheong et al., 2023</xref></td></tr><tr><td style="background-color: #FFF176;">Western diet</td><td style="background-color: #FFF176;">Mice</td><td style="background-color: #FFF176;">Metabolic trigger</td><td style="background-color: #FFF176;"><bold>IL-6</bold>, <bold>IFN-γ, IL-1β,</bold> G-CSF, GM-CSF</td><td style="background-color: #FFF176;">Lasting monocyte priming; GMP chromatin remodeling, differential gene expression, monocyte skewing</td><td style="background-color: #FFF176;"><xref ref-type="bibr" rid="bib8">Christ et al., 2018</xref></td></tr></tbody></table></table-wrap><p>β-Glucan and ligature-induced periodontitis (LIP), for example, are seemingly unrelated mouse models of hematopoietic reprogramming. Both, however, induce IL1β and similar hematopoietic reprogramming phenotypes. β-Glucan and LIP both induce a persistent myeloid bias at the level of LT-HSCs that is transplantable into naïve recipients and prime the hematopoietic system to more rapidly increase myeloid cell production in response to secondary challenges with either chemotherapy or LPS. Blockage of IL1β signaling abrogates the reprogramming of long-lived myeloid bias in response to β-glucan (<xref ref-type="bibr" rid="bib30">Mitroulis et al., 2018</xref>) and in the model of LIP also reduces the primed secretion of TNFα and IL6 by LIP-bone marrow-derived neutrophils and monocytes in response to LPS (<xref ref-type="bibr" rid="bib26">Li et al., 2022</xref>). In further support of the essential role of IL1β in encoding these responses at the level of LT-HSCs, studies have shown that IL1β itself is sufficient to drive the expression of PU.1, as well as macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) within long-term hematopoietic stem cells (LT-HSCs) to drive an intrinsic myeloid bias (<xref ref-type="bibr" rid="bib45">Pietras et al., 2016</xref>) at the very apex of the hematopoietic hierarchy.</p><p>Other stimulus-cytokine pairs further support the notion that the action of cytokines dictates hematopoietic reprogramming. In contrast to IL1β, inducers of IFNγ and IL6 appear to generate a hematopoietic reprogramming phenotype that more predominantly involves monocyte- (rather than neutrophil) skewed myeloid cell production and GMP/monocyte-centric reprogramming.</p><p>For example, vaccination with <italic>Bacillus</italic> Calmette-Guérin (BCG), a live attenuated version of <italic>Mycobacterium bovis,</italic> induces hematopoietic reprogramming in a manner that is dependent on IFNγ (<xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref>). In line with IFNγ’s intrinsic ability to polarize the bone marrow toward monocyte over granulocyte production, the main hematopoietic reprogramming phenotype of BCG is the production of macrophages with an increased ability to resist <italic>Mycobacterium tuberculosis</italic> infection in vitro even in mice treated with antibiotics, an effect which is lost completely in IFNγR KO mice (<xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref>).</p><p>COVID-19 induces hematopoietic reprogramming via a mechanism that appears to involve IL6. Often acting in concert with IFNγ, IL6 acts directly on MPPs by downregulating production of the TFs Cebpa and Runx1, thus further skewing downstream GMPs toward the monocyte lineage (<xref ref-type="bibr" rid="bib9">de Bruin et al., 2012</xref>). Accordingly, COVID infection can induce the persistence of elevated GMPs detected in the peripheral circulation for at least 4–12 months following exposure and leads to the production of epigenetically modified monocytes primed to secrete elevated levels of IL6 and TNF-α in response to TLR7/8 agonist R848 or IFNα (<xref ref-type="bibr" rid="bib7">Cheong et al., 2023</xref>). Treatment with Tocilizumab—an antibody which blocks IL6 signaling—leads to significantly reduced levels of the GMPs. Moreover, in a mouse model of COVID infection, concomitant treatment with anti-IL6 significantly decreased the post-COVID burden of inflammatory myeloid cells within both the lungs and brain (<xref ref-type="bibr" rid="bib7">Cheong et al., 2023</xref>).</p><p>Western diet is an interesting example of a stimulus that induces multiple cytokines simultaneously, including IL6, IFNγ, and IL1β. In line with the tendency for IL6 and IFNγ to reprogram HSPCs at the level of the GMP and monocyte, western diet hematopoietic reprogramming is also characterized by lasting effects on the chromatin accessibility and gene profiles of GMPs isolated even 4 weeks after return to a control diet, GMP skewing toward the monocyte lineage, and priming of both monocytes and GMPs. Although IL1β was markedly increased in this study, whether its effects on LT-HSCs resembled those of other IL1β producers, such as β-glucan, remains unclear (<xref ref-type="bibr" rid="bib8">Christ et al., 2018</xref>).</p><p>Altogether, the data suggest that the specific flavor of hematopoietic reprogramming that is induced by any given stimulus is influenced by the cytokines which they induce (<xref ref-type="table" rid="table1">Table 1</xref>). β-Glucan and LIP converge on IL-1β and in both examples, result in LT-HSCs with persistent myeloid bias and primed EM response to secondary challenges (<xref ref-type="bibr" rid="bib26">Li et al., 2022</xref>; <xref ref-type="bibr" rid="bib30">Mitroulis et al., 2018</xref>). Mycobacteria, which induce the monocyte/macrophage-polarizing cytokine IFNγ when injected intravenously, train the bone marrow of mice to give rise to macrophages with increased bacterial killing capacity (<xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref>). Models of human COVID infection and western diet in mice implicate IL-6 as a key cytokine in reprogramming the bone marrow at the level of monocytes and GMPs (<xref ref-type="bibr" rid="bib7">Cheong et al., 2023</xref>; <xref ref-type="bibr" rid="bib8">Christ et al., 2018</xref>). When taken together, existing data suggests that blocking the signaling of key cytokines involved in programming demand-adapted myeloid cell mobilization abrogates both EM and the ability of the hematopoietic system to become reprogrammed, suggesting that EM may be a necessary component of hematopoietic reprogramming. In some cases, administration of recombinant cytokines, such as IFNγ (<xref ref-type="bibr" rid="bib19">Kain et al., 2023</xref>), has also reproduced phenotypes of hematopoietic reprogramming, thereby also suggesting sufficiency. Nonetheless, there remains a need for more systematic necessity and sufficiency experiments to further delineate the exact role of each EM-inducing cytokine in hematopoietic reprogramming.</p></sec><sec id="s4"><title>Remodeling hematopoiesis: how TFs encode innate immune memory</title><sec id="s4-1"><title>The pioneer TF machinery of EM drives hematopoietic reprogramming</title><p>In addition to cytokine signaling, the induction of myeloid lineage directing TFs is an essential step in hematopoietic reprogramming. These include TFs such as PU.1 and C/EBPβ, which are notable for their ability to act as <italic>pioneer factors</italic> by binding to previously inaccessible chromatin and setting off a cascade of subsequent TF binding events. These and other pioneer factors are believed to act in concert to remodel the chromatin landscape such that the regulatory enhancers and promoters of myeloid cells remain open, while those of lymphoid lineage cells become inaccessible. Studies suggest that the same network of pioneering TFs may simultaneously imprint the physical chromatin ‘scars’ that underlie the phenotypes of hematopoietic reprogramming (<xref ref-type="bibr" rid="bib24">Larsen et al., 2021</xref>). In taking a systematic look at the TFs implicated in hematopoietic reprogramming across studies, we find that they are almost exclusively limited to pioneer TFs with previously known roles as, or acting in concert with, lineage-determining TFs (used to denote a subtype of pioneer factor which dictates hematopoietic lineage fate).</p><p>In an attempt to gain clarity, we have organized these TFs into four groups according to the specificity with which they are activated:</p><list list-type="order" id="list1"><list-item><p>C/EBPβ, which is a lineage-determining TF specific to and required for EM.</p></list-item><list-item><p>STATs, which are critical in cytokine-induced EM but also important in mounting inflammatory responses in many other contexts outside of hematopoiesis.</p></list-item><list-item><p>The AP-1 TFs FOS and JUN, which are pioneer factors ubiquitously induced not only in EM but in response to most stimuli.</p></list-item><list-item><p>Universally cooperative factors—SP/KLF, EGR, MAZ, and ZNF—which are not specifically implicated in EM but have been shown to universally engage in highly cooperative binding and in prolonging the chromatin binding time of their partner TFs (<xref ref-type="table" rid="table2">Table 2</xref>).</p></list-item></list><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Transcription factors (TFs) implicated in hematopoietic reprogramming fall into four groups.</title><p>These range from TFs that are activated and bind chromatin in specific contexts (such as emergency myelopoiesis [EM] for CEBPB) to those that engage in widespread binding and play roles in dictating the global chromatin landscape (stripe factors). Check marks on the right indicate TF involvement within each study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="3">TF group</th><th align="left" valign="bottom" rowspan="3">TF function specificity</th><th align="left" valign="bottom" rowspan="3">Key members</th><th align="left" valign="bottom" rowspan="3">Role in hematopoietic reprogramming</th><th align="left" valign="bottom" colspan="6">Models/Stimuli with evidence of TF group involvement</th></tr><tr><th align="left" valign="bottom" colspan="4">Mouse</th><th align="left" valign="bottom" colspan="2">Human</th></tr><tr><th align="left" valign="bottom">β-Glucan</th><th align="left" valign="bottom">BCG</th><th align="left" valign="bottom">LPS</th><th align="left" valign="bottom">Western diet</th><th align="left" valign="bottom">BCG</th><th align="left" valign="bottom">COVID</th></tr></thead><tbody><tr><td align="left" valign="bottom">Lineage</td><td align="left" valign="bottom">+</td><td align="left" valign="bottom">C/EBP (β, α, ε, δ)</td><td align="left" valign="bottom">Required for cytokine-induced EM; downstream of G-CSF through STAT3</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td></tr><tr><td align="left" valign="bottom">Cytokine responsive</td><td align="left" valign="bottom">+ +</td><td align="left" valign="bottom">STAT1, STAT3, STAT5</td><td align="left" valign="bottom">Mediates cytokine signaling (IL6, IFNs, G-CSF)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td></tr><tr><td align="left" valign="bottom">Ubiquitous pioneer</td><td align="left" valign="bottom">+ + +</td><td align="left" valign="bottom">FOS/JUN (AP-1)</td><td align="left" valign="bottom">Induced in many stimuli; drive enhancer formation and chromatin access</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td></tr><tr><td align="left" valign="bottom">Universal stripe</td><td align="left" valign="bottom">+ + +</td><td align="left" valign="bottom">KLFs, SPs, EGRs, ZNFs</td><td align="left" valign="bottom">Enables through co-binding other TFs shaping epigenetic landscape</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td></tr></tbody></table></table-wrap><p>To briefly elaborate on the functions of these four groups of TFs: The first group consists of C/EBPb—a member of the C/EBP family of TFs which share a highly conserved C-terminus leucine zipper dimerization domain, adjacent to a basic DNA binding domain (bZIP) (<xref ref-type="bibr" rid="bib23">Landschulz et al., 1989</xref>). The most important role of C/EBPb is in cytokine-induced emergency granulopoiesis (<xref ref-type="bibr" rid="bib18">Hirai et al., 2006</xref>). It is induced in response to G-CSF (universally important in EM and often induced concomitantly with other cytokines) signaling which triggers CEBPβ activation through the activation of JAK-STAT3. C/EBPb and STAT3 bind to the promoters of various cell cycle genes, such as c-Myc, leading to GMP proliferation (<xref ref-type="bibr" rid="bib28">Manz and Boettcher, 2014</xref>; <xref ref-type="bibr" rid="bib56">Zhang et al., 2010</xref>). C/EBPb is also induced within HSPCs higher up the differentiation tree, such as in LT-HSCs (<xref ref-type="bibr" rid="bib10">de Laval et al., 2020</xref>). C/EBPε has also been implicated in some studies and is involved in the terminal differentiation of granulocytes (<xref ref-type="bibr" rid="bib53">Yamanaka et al., 1997</xref>).</p><p>STAT TFs differ from C/EBP in that they not only orchestrate EM, but also play a dual role in driving inflammatory gene expression responses in response to cytokine stimulation of terminally differentiated cells. JAK inhibition in the context of cytokine stimulation, which blocks the ability to activate STATs, prevents PU.1 binding and the deposition of histone modifications (<xref ref-type="bibr" rid="bib38">Ostuni et al., 2013</xref>), providing further evidence that chromatin opening in response to inflammatory cytokines is instigated by STATs. In the context of EM, STATs 1, 3, and 5 are directly upregulated by G-CSF stimulation (<xref ref-type="bibr" rid="bib28">Manz and Boettcher, 2014</xref>). IL6 also induces the expression of Stat3 (which binds to regulatory regions together with C/EBPβ as discussed above), and GM-CSF upregulates STAT5a and STAT5b. Interferons activate STAT1, which can form a complex with STAT2 and IRF9 (ISGF3), which recruits chromatin remodelers SWI/SNF, HATs, and HDACs (<xref ref-type="bibr" rid="bib44">Philips et al., 2022</xref>).</p><p>The third group of TFs, AP-1 TFs, has established roles as pioneer factors with de novo enhancer formation in EM but is also generally responsive to most stimuli in most tissues, and thus modulates chromatin in a plethora of contexts. Thus, they can be differentiated from STATs in that they respond to a broader range of stimuli. For example, exposure of mouse fibroblasts to serum induces the AP-1 binding to several de novo sites and association of AP-1 with components of the BAF chromatin remodeling complex (<xref ref-type="bibr" rid="bib51">Vierbuchen et al., 2017</xref>). Ap-1 TFs are often reported to bind in combination with more specific TFs. In a survey of other studies, it was noted that factors co-enriched with AP-1 are often cell-type specific, such as C/EBPb in macrophages and NFAT in T-cells (<xref ref-type="bibr" rid="bib51">Vierbuchen et al., 2017</xref>), suggesting that AP-1 may instigate chromatin opening to invite a second layer of more specific TF binding.</p><p>The final group of TFs is connected by their universal cooperative binding patterns. A recent study (<xref ref-type="bibr" rid="bib58">Zhao et al., 2022</xref>) called such factors ‘stripe’ factors for the prominent vertical lines they formed on colocalization heatmaps as a result of their tendency to colocalize with most other TFs. Notable members included KLF, SP, EGR, ZNF, ZBTB, MAZ, PATZ1, and RREB1—all containing C2H2 zinc finger domains. SNPs affecting universal stripe factor binding have been shown to have a larger impact on chromatin accessibility than did SNPs targeting other TFs (<xref ref-type="bibr" rid="bib58">Zhao et al., 2022</xref>), suggesting an integral role of USFs in dictating global chromatin architecture.</p></sec><sec id="s4-2"><title>Stimulus-specific combinations of TFs shape hematopoietic reprogramming</title><p>The TF groups described above are not activated in isolation but are selectively engaged depending on the stimulus and the cytokines it induces. Below, we summarize evidence from key models of hematopoietic reprogramming to illustrate how these transcriptional programs are deployed in vivo.</p><p>The stimuli that lead to hematopoietic reprogramming engage various combinations of TFs from these classes. LPS in mice, for example, leads to persistent changes in chromatin accessibility in LT-HSCs that can be transplanted into naïve hosts to confer significant protection against <italic>Pseudomonas aeruginosa</italic> infection. These sites of altered chromatin accessibility enrich significantly for CEBPB, as well as the AP-1 members FOS and JUN (<xref ref-type="bibr" rid="bib10">de Laval et al., 2020</xref>). The hematopoietic reprogramming stimulus β-glucan (which induces persistent LT-HSC bias in an IL1β-dependent manner as described above) induces changes in the gene expression of CEBPε targets after 7 days, again implicating the CEBP family (<xref ref-type="bibr" rid="bib30">Mitroulis et al., 2018</xref>). In mice, BCG most predominantly modulates the expression of STAT1 downstream of IFNγ to reprogram bone marrow-derived macrophages to engage in heightened mycobacterium killing capacity (<xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref>). Of note, epidermal skin stem cells form epigenetic memories in response to topical imiquimod via the formation of STAT3, FOS, and JUN complexes. Once activated by imiquimod, STAT3 recruits FOS and JUN, with JUN acting as a bookmarker. On heterologous stimulation, FOS rapidly reassociates with JUN, enabling faster gene expression to secondary injury (<xref ref-type="bibr" rid="bib24">Larsen et al., 2021</xref>). While not demonstrated to the same level of mechanistic detail within hematopoietic stem cells, the example is consistent with the observation that small combinations of TFs drawn from STATs, AP-1, CEBP, or stripe factor TFs can orchestrate epigenetic memories.</p><p>Other stimuli engage broader swaths of TFs across larger number of classes. The universal stripe factors KLF4 and EGR1, concomitant with FOS/JUN and STAT TF activities, were implicated in western diet-reprogrammed GMPs after 4 weeks (<xref ref-type="bibr" rid="bib8">Christ et al., 2018</xref>). Human studies, primarily of COVID or BCG, of hematopoietic reprogramming have also provided invaluable insights into the range of TFs implicated in hematopoietic reprogramming. COVID, for which IL6 signaling is critical for hematopoietic reprogramming, engages TFs of all four classes. Blockage of IL6 reduces the level of persistent C/EBPε and C/EBPβ activities found in late samples (4–12 months post-COVID), implicating the CEBP TFs downstream of IL6 in hematopoietic reprogramming. COVID infection also induces persistent changes in chromatin accessibility around STAT3, increased activity of FOS and JUN in HSPCs and monocytes 4–12 months post infection, and differential expression of KLF2 in HSPC 4–12 months post infection (<xref ref-type="bibr" rid="bib7">Cheong et al., 2023</xref>).</p><p>Similarly, human intradermal vaccination with BCG leads to persistent changes in the chromatin accessibility of CMPs and GMPs at sites that enrich for TFs of all four classes (including CEBPB, STAT1, FOS, JUN, and TF motifs in the KLF/SP and EGR families) but for which stripe factors have the strongest enrichments. Out of the 11 TF motif families enriched within CMP and GMP progenitors with concomitant evidence of altered TF activity within HSCs upstream, six, including ‘ZNF/MAZ’, ‘KLF/SP_2’, ‘EGR1/2/3/4’, ‘KLF/SP_1’, ‘KLF2/3/6’, and ‘ZNF24’, overlapped those labeled as universal stripe factors (<xref ref-type="bibr" rid="bib49">Sun et al., 2024</xref>). Thus, it appears that in the context of subcutaneous BCG vaccination of humans, persistently altered activity of stripe factors in HSCs and downstream changes in chromatin accessibility within progenitors at sites bound by these TFs is a key feature of the resultant hematopoiesis reprogramming.</p><p>Taken together, these studies suggest that all stimuli of hematopoietic reprogramming converge on the need to engage chromatin remodeling through pioneer or cooperative TFs. While this mechanism appears conserved, the specific TFs engaged differ by stimulus, likely due to variation in the cytokine milieu. In support of this hypothesis, both western diet and COVID-19 infections implicate IL-6 as upregulated cytokines, and both engage TFs from larger numbers of classes (3–4) compared to, for example, the IL1β inducer β-glucan, or the interferon inducer BCG in mice (<xref ref-type="table" rid="table2">Table 2</xref>). Still, the current body of literature emphasizes the need for larger numbers of studies which use the same stimuli in both mice and humans and which collect the same measurements (many studies measure cytokines or TFs but not both, and some measure TF activity through gene expression while others use chromatin accessibility measurements) to decrease the number of confounding variables that complicate interpretation of the current literature.</p></sec></sec><sec id="s5"><title>Species may matter: TF usage in mouse vs. human hematopoietic reprogramming</title><p>While <xref ref-type="table" rid="table2">Table 2</xref> suggests that hematopoietic reprogramming is driven by different combinations of TFs because of different stimuli, we also reasoned that species-specific factors, rather than specific stimuli, may explain some of these differences. We noticed that the studies in mice (<xref ref-type="bibr" rid="bib8">Christ et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">de Laval et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Mitroulis et al., 2018</xref>) generally contained TF representatives from fewer numbers of our TF classes compared to the studies in humans (<xref ref-type="bibr" rid="bib7">Cheong et al., 2023</xref>; <xref ref-type="bibr" rid="bib49">Sun et al., 2024</xref>). These TF classes were, of course, artificially defined by us and not based on any formal structural or evolutionary similarity. In an attempt to more objectively compare TF usage in hematopoietic reprogramming across species, we analyzed TF motif enrichment data from three studies spanning human and mouse HSPCs, alongside TF differential expression data from HSCs in Kaufmann et al. (which did not include chromatin accessibility data) and a mouse dataset of COVID infection published alongside the human data in Cheong et al. Studies in <xref ref-type="table" rid="table2">Table 2</xref> without published datasets on TF expression or motif enrichment were not included. For each of the five included datasets, TF motif enrichment FDR values—or differential gene expression FDR values in the case of Kaufmann et al.—were ranked from most to least significant. This ranking enabled cross-study comparisons of preferential TF usage. We then focused on a combined set of TFs implicated in the literature as important in hematopoietic reprogramming in either mouse, human, or both, as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Viewing the data in this manner, albeit limited by small sample sizes in differences in data modalities, revealed an overall consistent usage of TFs across species and conditions. Hierarchical clustering suggests that differences between studies are likely influenced not only by stimulus but also species (<xref ref-type="fig" rid="fig1">Figure 1</xref>), thus TF utilization in hematopoietic reprogramming may be shaped by a complex interplay of factors, including stimulus type (live vs. inert), stimulus class (virus vs. bacteria), stimulus dose, and host species (mouse vs. human). While some TFs were enriched in a study-specific manner (e.g. EGR3 being solely enriched within human HSPCs following BCG vaccination), others displayed enrichment patterns suggestive of specificity to one species or infectious stimulus. FOS was enriched within all studies involving live infectious agents, but not in LPS injection. TFs such as MAZ and SP1 were most strongly enriched in the human studies compared to mice, being among the top quarter of most enriched motifs in humans vaccinated with BCG or infected with COVID-19, but not their mouse counterparts. In support of the idea that human hematopoietic reprogramming may involve larger complexes of factors, human studies had larger numbers of total enriched TFs compared to mouse studies of the same stimulus (human/mouse: BCG = 746/635; COVID 423/378; LPS NA/97). Nonetheless, the highly congruent TF enrichments between mouse and human COVID-infected HSPCs (both published in Jeong et al.) suggest that a significant portion of species-specific differences may be confounded by differences in the stimuli typically used. Extended versions of such analyses could provide better context for understanding the roles of different enriched TFs as either species or stimulus-specific responders.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Heatmap of human and mouse studies with transcription factors (TFs) colored according to their ranked motif or expression (Bacillus Calmette–Guérin [BCG] mouse) enrichment within hematopoietic stem and progenitor cells (HSPCs) 1 or more months following training with the indicated stimulus.</title><p>Each column represents a different study. Studies are grouped by stimulus type (top gray boxes). Species (mouse or human) is indicated on the bottom x-axis. White squares indicate no significant enrichment (NE).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107551-fig1-v1.tif"/></fig></sec><sec id="s6"><title>Selective constraint on TFs involved in trained immunity</title><p>Despite some evidence for species-specific differences in TF usage in hematopoietic reprogramming, the data in <xref ref-type="fig" rid="fig1">Figure 1</xref> suggest a high degree of overall similarity between humans and mice, especially when comparing studies that used the same stimulus (e.g. COVID). This functional conservation reinforces the biological relevance of the trained immunity program across species.</p><p>A major goal in human genetics is to identify genes that are important for disease susceptibility and fitness. One useful way to assess the biological importance of a gene is to measure its level of selective constraint—i.e., how strongly natural selection acts to eliminate deleterious variants from the population (<xref ref-type="bibr" rid="bib1">Agarwal et al., 2023</xref>; <xref ref-type="bibr" rid="bib14">Fuller et al., 2019</xref>). Genes that are under strong purifying selection will show a marked depletion of loss-of-function (LOF) variants, indicating that disruptions to their function reduce fitness and are thus selected against. We reasoned that if the genes central to trained immunity, such as the cytokines and TFs discussed above, are important for human immune adaptation and ultimately survival, particularly in the context of infectious disease, they should exhibit strong selective constraint. To test this, we analyzed gene-level LOF constraint metrics derived from the gnomAD v2.1 dataset, which includes exome sequences from approximately 125,000 individuals spanning 19,071 protein-coding genes (<xref ref-type="bibr" rid="bib20">Karczewski et al., 2020</xref>). Specifically, we examined <italic>shet</italic>, a measure of the fitness reduction associated with carrying one copy of an LOF variant in each gene (<xref ref-type="bibr" rid="bib55">Zeng et al., 2024</xref>). Larger <italic>shet</italic> values indicate stronger selection against LOF variants and, by extension, greater importance to fitness; smaller values suggest either tolerance to disruption or functional redundancy.</p><p>We focused on the key effector molecules and TFs (described above in this review) as core components of the trained immunity program. When compared to the genome-wide distribution of <italic>shet</italic> values, we found that TFs involved in trained immunity show some of the highest levels of selective constraint across the human genome (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Notably, this elevated constraint is not simply a reflection of their being TFs; even when compared specifically to all TFs in the genome, those implicated in trained immunity are significantly more constrained (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Conservation scores (<italic>shet</italic>) for cytokines (green) and transcription factors (TFs) (purple) implicated across mouse and human studies of hematopoietic reprogramming, compared to all other genes (gray).</title><p>The figure shows posterior distributions of <italic>shet</italic> for individual genes, ordered by mean. Lines represent 95% credible intervals, with labeled genes represented by thick black lines. Colors represent the selection regimes. The inset panel summarizes <italic>shet</italic> values for TFs involved in hematopoietic reprogramming (HR-TFs), comparing them to all other TFs and to the rest of the genome.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107551-fig2-v1.tif"/></fig><p>This suggests that these genes play essential roles in human fitness and survival. Stripe TFs such as KLF6, KLF2, EGR3, SP1, and MAZ are among the most constrained genes in the trained immunity network, and the genome overall.</p><p>These TFs are known to play critical and broadly pleiotropic roles in chromatin regulation, cell fate decisions, and stress responses, often in coordination with lineage-specific factors. For example, KLF6 is essential for hematopoietic stem cell quiescence and vascular development, and germline inactivation in mice results in embryonic lethality (<xref ref-type="bibr" rid="bib3">Bialkowska et al., 2017</xref>). SP1 is a master regulator involved in the transcription of thousands of genes, including those required for immune responses, metabolism, and cell cycle control; mutations are associated with severe multisystem developmental syndromes. Finally, EGR3 regulates both neuronal development and T-cell activation; although rare, LOF mutations are linked to immune dysfunction and neurodevelopmental phenotypes (<xref ref-type="bibr" rid="bib25">Li et al., 2007</xref>).</p><p>The extreme constraint on these genes underscores their nonredundant, dosage-sensitive roles, making even partial loss deleterious. While these TFs are involved in a range of biological processes beyond trained immunity, their central positioning in immune regulatory networks likely contributes to their evolutionary conservation. This supports the idea that mechanisms underpinning trained immunity—especially those related to chromatin remodeling and transcriptional reprogramminghave been subject to strong selective pressures, likely due to their impact on host survival in the face of infection.</p><p>In contrast, many effector molecules in the trained immunity network show lower levels of constraint, even though they play important roles in immune responses. For instance, IL6 and IL1β, both critical mediators of inflammatory responses and trained immunity, exhibit moderate to low <italic>shet</italic> values. This suggests that partial or even complete LOF variants in these genes are compatible with survival and may have relatively mild phenotypic consequences.</p><p>Indeed, common variants in IL6, IL1β, and related cytokine genes are found at appreciable frequencies in the general population, including missense and regulatory variants that modulate expression or function (<xref ref-type="bibr" rid="bib15">Gong et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Ołdakowska et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Smith and Humphries, 2009</xref>). Some of these are associated with variation in infection susceptibility, inflammatory disease risk, or vaccine responsiveness, but they rarely cause severe monogenic disorders. For example, polymorphisms in the IL6 promoter have been associated with differences in CRP levels and outcomes in sepsis or COVID-19 but are not causative of immunodeficiency (<xref ref-type="bibr" rid="bib15">Gong et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Ołdakowska et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Smith and Humphries, 2009</xref>).</p><p>This pattern is consistent with functional redundancy in cytokine networks: many cytokines share receptor subunits (e.g. IL-6 and IL-11 signaling through gp130) or activate overlapping downstream pathways such as JAK-STAT (<xref ref-type="bibr" rid="bib31">Murakami et al., 2019</xref>). In this modular architecture, TFs act as essential convergence points, integrating signals from diverse upstream cues, while individual cytokines may be more expendable or context-specific.</p><p>Taken together, these data support a model in which trained immunity relies on a robust and evolutionarily constrained transcriptional core, built on TFs that are indispensable for orchestrating broad and durable responses. In contrast, upstream effector molecules exhibit greater flexibility, reflecting both their redundancy and the adaptive value of variation in cytokine responsiveness across diverse human environments.</p></sec><sec id="s7"><title>Conclusion and future directions</title><p>The extension of trained immunity to the hematopoietic compartment has revealed that diverse stimuli—both inert and infectious—can durably reprogram the lineage biases, epigenetic landscapes, and transcriptional circuits of LT-HSCs. While this diversity of stimuli has posed interpretive challenges, it has also clarified common mechanisms: hematopoietic reprogramming is consistently initiated by EM, typically coordinated by cytokines such as IL-1β, IL-6, and IFN-γ acting on LT-HSCs. Downstream, the activation of pioneer and lineage-determining TFs capable of remodeling chromatin likely constitutes the next critical step in encoding immune memory.</p><p>Comparative analyses suggest that mouse models often engage fewer TFs than human studies—whether this reflects true species-specific biology, experimental tractability, or differences in stimulus remains unclear. However, many of the TFs implicated in hematopoietic reprogramming, particularly those involved in chromatin remodeling and lineage specification, are among the most evolutionarily constrained genes in the human genome. This constraint likely reflects their indispensable roles in core developmental and cellular processes, rather than any selection pressure specific to trained immunity. Instead, trained immunity may have emerged, at least in part, as a byproduct of the reuse of this deeply conserved transcriptional architecture in the context of infection and inflammation.</p><p>Looking ahead, trained immunity offers a powerful framework for exploring fundamental questions: How is epigenetic memory maintained in self-renewing cells? How do cells preserve core identity while flexibly adapting to environmental challenges? Self-sustaining TF circuits—like the Myc-Wnt/β-catenin loop in embryonic stem cells (<xref ref-type="bibr" rid="bib12">Fagnocchi et al., 2016</xref>) or the IRF-KLF-SPI network in DC development (<xref ref-type="bibr" rid="bib27">Lin et al., 2015</xref>)—may provide a useful blueprint. Whether similar circuits exist in reprogrammed HSPCs remains to be explored.</p><p>A key frontier lies in decoding the thresholds that separate transient adaptation from long-term memory. Are these governed by the intensity, duration, or type of stimulusor by a combinatorial logic yet to be defined? Elucidating these parameters will not only advance our understanding of hematopoietic reprogramming and trained immunity, but also inform broader questions in immunology and regenerative medicine, from T-cell fate decisions to the design of durable cellular therapies and improved patient stratification strategies.</p></sec></body><back><sec sec-type="additional-information" id="s8"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing – review and editing</p></fn></fn-group></sec><ack id="ack"><title>Acknowledgements</title><p>We thank all members of the Barreiro lab for their insightful comments. This study was supported by grant R35-GM152227, R01-AI182148, and R01-AI190301 to LBB, and the UChicago DDRCC, Center for Interdisciplinary Study of Inflammatory Intestinal Disorders (C-IID) (NIDDK P30 DK042086). SS was supported by the MSTP training grant T32GM150375.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>I</given-names></name><name><surname>Fuller</surname><given-names>ZL</given-names></name><name><surname>Myers</surname><given-names>SR</given-names></name><name><surname>Przeworski</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Relating pathogenic loss-of-function mutations in humans to their evolutionary fitness costs</article-title><source>eLife</source><volume>12</volume><elocation-id>e83172</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.83172</pub-id><pub-id pub-id-type="pmid">36648429</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekkering</surname><given-names>S</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>van der Heijden</surname><given-names>CDCC</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Popa</surname><given-names>CD</given-names></name><name><surname>Ter Horst</surname><given-names>R</given-names></name><name><surname>van Tuijl</surname><given-names>J</given-names></name><name><surname>Netea-Maier</surname><given-names>RT</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Stunnenberg</surname><given-names>H</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metabolic induction of trained immunity through the mevalonate pathway</article-title><source>Cell</source><volume>172</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.025</pub-id><pub-id pub-id-type="pmid">29328908</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bialkowska</surname><given-names>AB</given-names></name><name><surname>Yang</surname><given-names>VW</given-names></name><name><surname>Mallipattu</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Krüppel-like factors in mammalian stem cells and development</article-title><source>Development</source><volume>144</volume><fpage>737</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1242/dev.145441</pub-id><pub-id pub-id-type="pmid">28246209</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation</article-title><source>Nature Immunology</source><volume>20</volume><fpage>802</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0402-5</pub-id><pub-id pub-id-type="pmid">31213716</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inflammatory modulation of hematopoiesis: linking trained immunity and clonal hematopoiesis with chronic disorders</article-title><source>Annual Review of Physiology</source><volume>84</volume><fpage>183</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-052521-013627</pub-id><pub-id pub-id-type="pmid">34614373</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S-C</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Cramer</surname><given-names>RA</given-names></name><name><surname>Shepardson</surname><given-names>KM</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name><name><surname>Aghajanirefah</surname><given-names>A</given-names></name><name><surname>Manjeri</surname><given-names>GR</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>van der Veer</surname><given-names>BMJW</given-names></name><name><surname>Deen</surname><given-names>PMT</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>O’Neill</surname><given-names>LA</given-names></name><name><surname>Willems</surname><given-names>P</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity</article-title><source>Science</source><volume>345</volume><elocation-id>1250684</elocation-id><pub-id pub-id-type="doi">10.1126/science.1250684</pub-id><pub-id pub-id-type="pmid">25258083</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>JG</given-names></name><name><surname>Ravishankar</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Parkhurst</surname><given-names>CN</given-names></name><name><surname>Grassmann</surname><given-names>SA</given-names></name><name><surname>Wingert</surname><given-names>CK</given-names></name><name><surname>Laurent</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Paddock</surname><given-names>L</given-names></name><name><surname>Miranda</surname><given-names>IC</given-names></name><name><surname>Karakaslar</surname><given-names>EO</given-names></name><name><surname>Nehar-Belaid</surname><given-names>D</given-names></name><name><surname>Thibodeau</surname><given-names>A</given-names></name><name><surname>Bale</surname><given-names>MJ</given-names></name><name><surname>Kartha</surname><given-names>VK</given-names></name><name><surname>Yee</surname><given-names>JK</given-names></name><name><surname>Mays</surname><given-names>MY</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Daman</surname><given-names>AW</given-names></name><name><surname>Martinez de Paz</surname><given-names>A</given-names></name><name><surname>Ahimovic</surname><given-names>D</given-names></name><name><surname>Ramos</surname><given-names>V</given-names></name><name><surname>Lercher</surname><given-names>A</given-names></name><name><surname>Nielsen</surname><given-names>E</given-names></name><name><surname>Alvarez-Mulett</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Earl</surname><given-names>A</given-names></name><name><surname>Yallowitz</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>L</given-names></name><name><surname>LaFond</surname><given-names>E</given-names></name><name><surname>Weidman</surname><given-names>KL</given-names></name><name><surname>Racine-Brzostek</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>HS</given-names></name><name><surname>Price</surname><given-names>DR</given-names></name><name><surname>Leyre</surname><given-names>L</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Borczuk</surname><given-names>AC</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name><name><surname>Jones</surname><given-names>RB</given-names></name><name><surname>Schenck</surname><given-names>EJ</given-names></name><name><surname>Kaner</surname><given-names>RJ</given-names></name><name><surname>Chadburn</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Niec</surname><given-names>RE</given-names></name><name><surname>Barrat</surname><given-names>FJ</given-names></name><name><surname>Lief</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Ucar</surname><given-names>D</given-names></name><name><surname>Josefowicz</surname><given-names>SZ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Epigenetic memory of coronavirus infection in innate immune cells and their progenitors</article-title><source>Cell</source><volume>186</volume><fpage>3882</fpage><lpage>3902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.07.019</pub-id><pub-id pub-id-type="pmid">37597510</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>A</given-names></name><name><surname>Günther</surname><given-names>P</given-names></name><name><surname>Lauterbach</surname><given-names>MAR</given-names></name><name><surname>Duewell</surname><given-names>P</given-names></name><name><surname>Biswas</surname><given-names>D</given-names></name><name><surname>Pelka</surname><given-names>K</given-names></name><name><surname>Scholz</surname><given-names>CJ</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Haendler</surname><given-names>K</given-names></name><name><surname>Baßler</surname><given-names>K</given-names></name><name><surname>Klee</surname><given-names>K</given-names></name><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Ulas</surname><given-names>T</given-names></name><name><surname>Moorlag Simone</surname><given-names>JCFM</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Groh</surname><given-names>LA</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Espevik</surname><given-names>T</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Fitzgerald</surname><given-names>ML</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Western diet triggers NLRP3-dependent innate immune reprogramming</article-title><source>Cell</source><volume>172</volume><fpage>162</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.013</pub-id><pub-id pub-id-type="pmid">29328911</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bruin</surname><given-names>AM</given-names></name><name><surname>Libregts</surname><given-names>SF</given-names></name><name><surname>Valkhof</surname><given-names>M</given-names></name><name><surname>Boon</surname><given-names>L</given-names></name><name><surname>Touw</surname><given-names>IP</given-names></name><name><surname>Nolte</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>IFNγ induces monopoiesis and inhibits neutrophil development during inflammation</article-title><source>Blood</source><volume>119</volume><fpage>1543</fpage><lpage>1554</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-07-367706</pub-id><pub-id pub-id-type="pmid">22117048</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Laval</surname><given-names>B</given-names></name><name><surname>Maurizio</surname><given-names>J</given-names></name><name><surname>Kandalla</surname><given-names>PK</given-names></name><name><surname>Brisou</surname><given-names>G</given-names></name><name><surname>Simonnet</surname><given-names>L</given-names></name><name><surname>Huber</surname><given-names>C</given-names></name><name><surname>Gimenez</surname><given-names>G</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Reinhardt</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Leutz</surname><given-names>A</given-names></name><name><surname>Nadel</surname><given-names>B</given-names></name><name><surname>Bordi</surname><given-names>C</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Sarrazin</surname><given-names>S</given-names></name><name><surname>Sieweke</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>C/EBPβ-dependent epigenetic memory induces trained immunity in hematopoietic stem cells</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>657</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.01.017</pub-id><pub-id pub-id-type="pmid">32169166</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Bekkering</surname><given-names>S</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name><name><surname>DiNardo</surname><given-names>AR</given-names></name><name><surname>Dominguez-Andres</surname><given-names>J</given-names></name><name><surname>Duivenvoorden</surname><given-names>R</given-names></name><name><surname>Fanucchi</surname><given-names>S</given-names></name><name><surname>Fayad</surname><given-names>Z</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Hamon</surname><given-names>M</given-names></name><name><surname>Jeffrey</surname><given-names>KL</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><name><surname>Matarese</surname><given-names>G</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Mhlanga</surname><given-names>M</given-names></name><name><surname>Moorlag Simone</surname><given-names>JCFM</given-names></name><name><surname>Mulder</surname><given-names>WJM</given-names></name><name><surname>Naik</surname><given-names>S</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>O’Neill</surname><given-names>L</given-names></name><name><surname>Ochando</surname><given-names>J</given-names></name><name><surname>Ozato</surname><given-names>K</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Sauerwein</surname><given-names>R</given-names></name><name><surname>Sherwood</surname><given-names>ER</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Sieweke</surname><given-names>MH</given-names></name><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>Stunnenberg</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>Weis</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Xavier</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Trained immunity, tolerance, priming and differentiation: distinct immunological processes</article-title><source>Nature Immunology</source><volume>22</volume><fpage>2</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-00845-6</pub-id><pub-id pub-id-type="pmid">33293712</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagnocchi</surname><given-names>L</given-names></name><name><surname>Cherubini</surname><given-names>A</given-names></name><name><surname>Hatsuda</surname><given-names>H</given-names></name><name><surname>Fasciani</surname><given-names>A</given-names></name><name><surname>Mazzoleni</surname><given-names>S</given-names></name><name><surname>Poli</surname><given-names>V</given-names></name><name><surname>Berno</surname><given-names>V</given-names></name><name><surname>Rossi</surname><given-names>RL</given-names></name><name><surname>Reinbold</surname><given-names>R</given-names></name><name><surname>Endele</surname><given-names>M</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Rocchigiani</surname><given-names>M</given-names></name><name><surname>Szkarłat</surname><given-names>Ż</given-names></name><name><surname>Oliviero</surname><given-names>S</given-names></name><name><surname>Dalton</surname><given-names>S</given-names></name><name><surname>Zippo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11903</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11903</pub-id><pub-id pub-id-type="pmid">27301576</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>SL</given-names></name><name><surname>Hargreaves</surname><given-names>DC</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Gene-specific control of inflammation by TLR-induced chromatin modifications</article-title><source>Nature</source><volume>447</volume><fpage>972</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1038/nature05836</pub-id><pub-id pub-id-type="pmid">17538624</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname><given-names>ZL</given-names></name><name><surname>Berg</surname><given-names>JJ</given-names></name><name><surname>Mostafavi</surname><given-names>H</given-names></name><name><surname>Sella</surname><given-names>G</given-names></name><name><surname>Przeworski</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Measuring intolerance to mutation in human genetics</article-title><source>Nature Genetics</source><volume>51</volume><fpage>772</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0383-1</pub-id><pub-id pub-id-type="pmid">30962618</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Hao</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Tuo</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Shuai</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19</article-title><source>Signal Transduction and Targeted Therapy</source><volume>7</volume><elocation-id>112</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-022-00923-1</pub-id><pub-id pub-id-type="pmid">35368020</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gourbal</surname><given-names>B</given-names></name><name><surname>Pinaud</surname><given-names>S</given-names></name><name><surname>Beckers</surname><given-names>GJM</given-names></name><name><surname>Van Der Meer</surname><given-names>JWM</given-names></name><name><surname>Conrath</surname><given-names>U</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Innate immune memory: an evolutionary perspective</article-title><source>Immunological Reviews</source><volume>283</volume><fpage>21</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/imr.12647</pub-id><pub-id pub-id-type="pmid">29664574</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Spann</surname><given-names>N</given-names></name><name><surname>Bertolino</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Laslo</surname><given-names>P</given-names></name><name><surname>Cheng</surname><given-names>JX</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Dayaram</surname><given-names>T</given-names></name><name><surname>Hetherington</surname><given-names>CJ</given-names></name><name><surname>Mizuno</surname><given-names>S</given-names></name><name><surname>Imanishi</surname><given-names>J</given-names></name><name><surname>Akashi</surname><given-names>K</given-names></name><name><surname>Tenen</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>C/EBPbeta is required for “emergency” granulopoiesis</article-title><source>Nature Immunology</source><volume>7</volume><fpage>732</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1038/ni1354</pub-id><pub-id pub-id-type="pmid">16751774</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kain</surname><given-names>BN</given-names></name><name><surname>Tran</surname><given-names>BT</given-names></name><name><surname>Luna</surname><given-names>PN</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Le</surname><given-names>DT</given-names></name><name><surname>Florez</surname><given-names>MA</given-names></name><name><surname>Maneix</surname><given-names>L</given-names></name><name><surname>Toups</surname><given-names>JD</given-names></name><name><surname>Morales-Mantilla</surname><given-names>DE</given-names></name><name><surname>Koh</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Jaksik</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Catic</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>CA</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse models</article-title><source>iScience</source><volume>26</volume><elocation-id>107596</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.107596</pub-id><pub-id pub-id-type="pmid">37664586</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Francioli</surname><given-names>LC</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Cummings</surname><given-names>BB</given-names></name><name><surname>Alföldi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Collins</surname><given-names>RL</given-names></name><name><surname>Laricchia</surname><given-names>KM</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Birnbaum</surname><given-names>DP</given-names></name><name><surname>Gauthier</surname><given-names>LD</given-names></name><name><surname>Brand</surname><given-names>H</given-names></name><name><surname>Solomonson</surname><given-names>M</given-names></name><name><surname>Watts</surname><given-names>NA</given-names></name><name><surname>Rhodes</surname><given-names>D</given-names></name><name><surname>Singer-Berk</surname><given-names>M</given-names></name><name><surname>England</surname><given-names>EM</given-names></name><name><surname>Seaby</surname><given-names>EG</given-names></name><name><surname>Kosmicki</surname><given-names>JA</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Tashman</surname><given-names>K</given-names></name><name><surname>Farjoun</surname><given-names>Y</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Poterba</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Seed</surname><given-names>C</given-names></name><name><surname>Whiffin</surname><given-names>N</given-names></name><name><surname>Chong</surname><given-names>JX</given-names></name><name><surname>Samocha</surname><given-names>KE</given-names></name><name><surname>Pierce-Hoffman</surname><given-names>E</given-names></name><name><surname>Zappala</surname><given-names>Z</given-names></name><name><surname>O’Donnell-Luria</surname><given-names>AH</given-names></name><name><surname>Minikel</surname><given-names>EV</given-names></name><name><surname>Weisburd</surname><given-names>B</given-names></name><name><surname>Lek</surname><given-names>M</given-names></name><name><surname>Ware</surname><given-names>JS</given-names></name><name><surname>Vittal</surname><given-names>C</given-names></name><name><surname>Armean</surname><given-names>IM</given-names></name><name><surname>Bergelson</surname><given-names>L</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>KM</given-names></name><name><surname>Covarrubias</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>S</given-names></name><name><surname>Ferriera</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Gentry</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Jeandet</surname><given-names>T</given-names></name><name><surname>Kaplan</surname><given-names>D</given-names></name><name><surname>Llanwarne</surname><given-names>C</given-names></name><name><surname>Munshi</surname><given-names>R</given-names></name><name><surname>Novod</surname><given-names>S</given-names></name><name><surname>Petrillo</surname><given-names>N</given-names></name><name><surname>Roazen</surname><given-names>D</given-names></name><name><surname>Ruano-Rubio</surname><given-names>V</given-names></name><name><surname>Saltzman</surname><given-names>A</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Tibbetts</surname><given-names>K</given-names></name><name><surname>Tolonen</surname><given-names>C</given-names></name><name><surname>Wade</surname><given-names>G</given-names></name><name><surname>Talkowski</surname><given-names>ME</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name><collab>Genome Aggregation Database Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title><source>Nature</source><volume>581</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id><pub-id pub-id-type="pmid">32461654</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>JL</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Mendonça</surname><given-names>LE</given-names></name><name><surname>Pacis</surname><given-names>A</given-names></name><name><surname>Tzelepis</surname><given-names>F</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>Grenier</surname><given-names>JC</given-names></name><name><surname>Mailhot-Léonard</surname><given-names>F</given-names></name><name><surname>Ahmed</surname><given-names>E</given-names></name><name><surname>Belle</surname><given-names>J</given-names></name><name><surname>Besla</surname><given-names>R</given-names></name><name><surname>Mazer</surname><given-names>B</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis</article-title><source>Cell</source><volume>172</volume><fpage>176</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id><pub-id pub-id-type="pmid">29328912</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaMarche</surname><given-names>NM</given-names></name><name><surname>Hegde</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>MD</given-names></name><name><surname>Maier</surname><given-names>BB</given-names></name><name><surname>Troncoso</surname><given-names>L</given-names></name><name><surname>Le Berichel</surname><given-names>J</given-names></name><name><surname>Hamon</surname><given-names>P</given-names></name><name><surname>Belabed</surname><given-names>M</given-names></name><name><surname>Mattiuz</surname><given-names>R</given-names></name><name><surname>Hennequin</surname><given-names>C</given-names></name><name><surname>Chin</surname><given-names>T</given-names></name><name><surname>Reid</surname><given-names>AM</given-names></name><name><surname>Reyes-Torres</surname><given-names>I</given-names></name><name><surname>Nemeth</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>OC</given-names></name><name><surname>Doroshow</surname><given-names>DB</given-names></name><name><surname>Rohs</surname><given-names>NC</given-names></name><name><surname>Gomez</surname><given-names>JE</given-names></name><name><surname>Veluswamy</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>N</given-names></name><name><surname>Venturini</surname><given-names>N</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Buckup</surname><given-names>M</given-names></name><name><surname>Figueiredo</surname><given-names>I</given-names></name><name><surname>Roudko</surname><given-names>V</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Karasuyama</surname><given-names>H</given-names></name><name><surname>Gonzalez-Kozlova</surname><given-names>E</given-names></name><name><surname>Gnjatic</surname><given-names>S</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>BD</given-names></name><name><surname>Hirsch</surname><given-names>FR</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Marron</surname><given-names>TU</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis</article-title><source>Nature</source><volume>625</volume><fpage>166</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1038/s41586-023-06797-9</pub-id><pub-id pub-id-type="pmid">38057662</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landschulz</surname><given-names>WH</given-names></name><name><surname>Johnson</surname><given-names>PF</given-names></name><name><surname>McKnight</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite</article-title><source>Science</source><volume>243</volume><fpage>1681</fpage><lpage>1688</lpage><pub-id pub-id-type="doi">10.1126/science.2494700</pub-id><pub-id pub-id-type="pmid">2494700</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>SB</given-names></name><name><surname>Cowley</surname><given-names>CJ</given-names></name><name><surname>Sajjath</surname><given-names>SM</given-names></name><name><surname>Barrows</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Carroll</surname><given-names>TS</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Establishment, maintenance, and recall of inflammatory memory</article-title><source>Cell Stem Cell</source><volume>28</volume><fpage>1758</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2021.07.001</pub-id><pub-id pub-id-type="pmid">34320411</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yun</surname><given-names>SH</given-names></name><name><surname>Keblesh</surname><given-names>J</given-names></name><name><surname>Trommer</surname><given-names>BL</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Radulovic</surname><given-names>J</given-names></name><name><surname>Tourtellotte</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory</article-title><source>Molecular and Cellular Neurosciences</source><volume>35</volume><fpage>76</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2007.02.004</pub-id><pub-id pub-id-type="pmid">17350282</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Saha</surname><given-names>G</given-names></name><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Ioannidis</surname><given-names>C</given-names></name><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities</article-title><source>Cell</source><volume>185</volume><fpage>1709</fpage><lpage>1727</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.03.043</pub-id><pub-id pub-id-type="pmid">35483374</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Chauvistré</surname><given-names>H</given-names></name><name><surname>Costa</surname><given-names>IG</given-names></name><name><surname>Gusmao</surname><given-names>EG</given-names></name><name><surname>Mitzka</surname><given-names>S</given-names></name><name><surname>Hänzelmann</surname><given-names>S</given-names></name><name><surname>Baying</surname><given-names>B</given-names></name><name><surname>Klisch</surname><given-names>T</given-names></name><name><surname>Moriggl</surname><given-names>R</given-names></name><name><surname>Hennuy</surname><given-names>B</given-names></name><name><surname>Smeets</surname><given-names>H</given-names></name><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Benes</surname><given-names>V</given-names></name><name><surname>Seré</surname><given-names>K</given-names></name><name><surname>Zenke</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic program and transcription factor circuitry of dendritic cell development</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>9680</fpage><lpage>9693</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1056</pub-id><pub-id pub-id-type="pmid">26476451</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manz</surname><given-names>MG</given-names></name><name><surname>Boettcher</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Emergency granulopoiesis</article-title><source>Nature Reviews. Immunology</source><volume>14</volume><fpage>302</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1038/nri3660</pub-id><pub-id pub-id-type="pmid">24751955</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B</given-names></name><name><surname>Ivashkiv</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Interferons and epigenetic mechanisms in training, priming and tolerance of monocytes and hematopoietic progenitors</article-title><source>Immunological Reviews</source><volume>323</volume><fpage>257</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1111/imr.13330</pub-id><pub-id pub-id-type="pmid">38567833</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Ruppova</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>LS</given-names></name><name><surname>Grzybek</surname><given-names>M</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Eugster</surname><given-names>A</given-names></name><name><surname>Troullinaki</surname><given-names>M</given-names></name><name><surname>Palladini</surname><given-names>A</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>Chatzigeorgiou</surname><given-names>A</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Beyer</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Isermann</surname><given-names>B</given-names></name><name><surname>Lesche</surname><given-names>M</given-names></name><name><surname>Petzold</surname><given-names>A</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Henry</surname><given-names>I</given-names></name><name><surname>Dahl</surname><given-names>A</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Zamboni</surname><given-names>N</given-names></name><name><surname>Mirtschink</surname><given-names>P</given-names></name><name><surname>Coskun</surname><given-names>Ü</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modulation of myelopoiesis progenitors is an integral component of trained immunity</article-title><source>Cell</source><volume>172</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.034</pub-id><pub-id pub-id-type="pmid">29328910</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Kamimura</surname><given-names>D</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pleiotropy and specificity: insights from the interleukin 6 family of cytokines</article-title><source>Immunity</source><volume>50</volume><fpage>812</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.027</pub-id><pub-id pub-id-type="pmid">30995501</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Trained Immunity: a memory for innate host defense</article-title><source>Cell Host &amp; Microbe</source><volume>9</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2011.04.006</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><name><surname>Mills</surname><given-names>KHG</given-names></name><name><surname>Natoli</surname><given-names>G</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>O’Neill</surname><given-names>LAJ</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Trained immunity: a program of innate immune memory in health and disease</article-title><source>Science</source><volume>352</volume><elocation-id>aaf1098</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaf1098</pub-id><pub-id pub-id-type="pmid">27102489</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Placek</surname><given-names>K</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens</article-title><source>Cell Host &amp; Microbe</source><volume>25</volume><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.12.006</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Mhlanga</surname><given-names>MM</given-names></name><name><surname>Mulder</surname><given-names>WJM</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Stabell Benn</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Defining trained immunity and its role in health and disease</article-title><source>Nature Reviews. immunology</source><volume>20</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0285-6</pub-id><pub-id pub-id-type="pmid">32132681</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Habibi</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>S-Y</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Davar</surname><given-names>R</given-names></name><name><surname>Megchelenbrink</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Kuznetsova</surname><given-names>T</given-names></name><name><surname>Kox</surname><given-names>M</given-names></name><name><surname>Zwaag</surname><given-names>J</given-names></name><name><surname>Matarese</surname><given-names>F</given-names></name><name><surname>van Heeringen</surname><given-names>SJ</given-names></name><name><surname>Janssen-Megens</surname><given-names>EM</given-names></name><name><surname>Sharifi</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Keramati</surname><given-names>F</given-names></name><name><surname>Schoonenberg</surname><given-names>V</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Pickkers</surname><given-names>P</given-names></name><name><surname>Heath</surname><given-names>S</given-names></name><name><surname>Gut</surname><given-names>I</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>β-glucan reverses the epigenetic state of LPS-induced immunological tolerance</article-title><source>Cell</source><volume>167</volume><fpage>1354</fpage><lpage>1368</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.034</pub-id><pub-id pub-id-type="pmid">27863248</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ołdakowska</surname><given-names>M</given-names></name><name><surname>Ściskalska</surname><given-names>M</given-names></name><name><surname>Kepinska</surname><given-names>M</given-names></name><name><surname>Marek</surname><given-names>G</given-names></name><name><surname>Milnerowicz</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Association of genetic variants in <italic>IL6</italic> Gene (rs1800795) with the concentration of inflammatory markers (IL-6, hs-CRP) and superoxide dismutase in the blood of patients with acute pancreatitis-preliminary findings</article-title><source>Genes</source><volume>13</volume><elocation-id>290</elocation-id><pub-id pub-id-type="doi">10.3390/genes13020290</pub-id><pub-id pub-id-type="pmid">35205334</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostuni</surname><given-names>R</given-names></name><name><surname>Piccolo</surname><given-names>V</given-names></name><name><surname>Barozzi</surname><given-names>I</given-names></name><name><surname>Polletti</surname><given-names>S</given-names></name><name><surname>Termanini</surname><given-names>A</given-names></name><name><surname>Bonifacio</surname><given-names>S</given-names></name><name><surname>Curina</surname><given-names>A</given-names></name><name><surname>Prosperini</surname><given-names>E</given-names></name><name><surname>Ghisletti</surname><given-names>S</given-names></name><name><surname>Natoli</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Latent enhancers activated by stimulation in differentiated cells</article-title><source>Cell</source><volume>152</volume><fpage>157</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.12.018</pub-id><pub-id pub-id-type="pmid">23332752</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pancer</surname><given-names>Z</given-names></name><name><surname>Cooper</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The evolution of adaptive immunity</article-title><source>Annual Review of Immunology</source><volume>24</volume><fpage>497</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.24.021605.090542</pub-id><pub-id pub-id-type="pmid">16551257</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>MD</given-names></name><name><surname>Le Berichel</surname><given-names>J</given-names></name><name><surname>Hamon</surname><given-names>P</given-names></name><name><surname>Wilk</surname><given-names>CM</given-names></name><name><surname>Belabed</surname><given-names>M</given-names></name><name><surname>Yatim</surname><given-names>N</given-names></name><name><surname>Saffon</surname><given-names>A</given-names></name><name><surname>Boumelha</surname><given-names>J</given-names></name><name><surname>Falcomatà</surname><given-names>C</given-names></name><name><surname>Tepper</surname><given-names>A</given-names></name><name><surname>Hegde</surname><given-names>S</given-names></name><name><surname>Mattiuz</surname><given-names>R</given-names></name><name><surname>Soong</surname><given-names>BY</given-names></name><name><surname>LaMarche</surname><given-names>NM</given-names></name><name><surname>Rentzeperis</surname><given-names>F</given-names></name><name><surname>Troncoso</surname><given-names>L</given-names></name><name><surname>Halasz</surname><given-names>L</given-names></name><name><surname>Hennequin</surname><given-names>C</given-names></name><name><surname>Chin</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>EP</given-names></name><name><surname>Reid</surname><given-names>AM</given-names></name><name><surname>Su</surname><given-names>M</given-names></name><name><surname>Cahn</surname><given-names>AR</given-names></name><name><surname>Koekkoek</surname><given-names>LL</given-names></name><name><surname>Venturini</surname><given-names>N</given-names></name><name><surname>Wood-Isenberg</surname><given-names>S</given-names></name><name><surname>D’souza</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Dawson</surname><given-names>T</given-names></name><name><surname>Nie</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><name><surname>Casanova-Acebes</surname><given-names>M</given-names></name><name><surname>Swirski</surname><given-names>FK</given-names></name><name><surname>Downward</surname><given-names>J</given-names></name><name><surname>Vabret</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>BD</given-names></name><name><surname>Marron</surname><given-names>TU</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis</article-title><source>Science</source><volume>386</volume><elocation-id>eadn0327</elocation-id><pub-id pub-id-type="doi">10.1126/science.adn0327</pub-id><pub-id pub-id-type="pmid">39236155</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascutti</surname><given-names>MF</given-names></name><name><surname>Erkelens</surname><given-names>MN</given-names></name><name><surname>Nolte</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Impact of viral infections on hematopoiesis: From beneficial to detrimental effects on bone marrow output</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>364</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00364</pub-id><pub-id pub-id-type="pmid">27695457</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>AA</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Yona</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease</article-title><source>Immunology</source><volume>163</volume><fpage>250</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1111/imm.13320</pub-id><pub-id pub-id-type="pmid">33555612</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellicci</surname><given-names>DG</given-names></name><name><surname>Koay</surname><given-names>HF</given-names></name><name><surname>Berzins</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>756</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0345-y</pub-id><pub-id pub-id-type="pmid">32581346</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philips</surname><given-names>RL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cheon</surname><given-names>H</given-names></name><name><surname>Kanno</surname><given-names>Y</given-names></name><name><surname>Gadina</surname><given-names>M</given-names></name><name><surname>Sartorelli</surname><given-names>V</given-names></name><name><surname>Horvath</surname><given-names>CM</given-names></name><name><surname>Darnell</surname><given-names>JE</given-names><suffix>Jr</suffix></name><name><surname>Stark</surname><given-names>GR</given-names></name><name><surname>O’Shea</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The JAK-STAT pathway at 30: much learned, much more to do</article-title><source>Cell</source><volume>185</volume><fpage>3857</fpage><lpage>3876</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.09.023</pub-id><pub-id pub-id-type="pmid">36240739</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietras</surname><given-names>EM</given-names></name><name><surname>Mirantes-Barbeito</surname><given-names>C</given-names></name><name><surname>Fong</surname><given-names>S</given-names></name><name><surname>Loeffler</surname><given-names>D</given-names></name><name><surname>Kovtonyuk</surname><given-names>LV</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Lakshminarasimhan</surname><given-names>R</given-names></name><name><surname>Chin</surname><given-names>CP</given-names></name><name><surname>Techner</surname><given-names>JM</given-names></name><name><surname>Will</surname><given-names>B</given-names></name><name><surname>Nerlov</surname><given-names>C</given-names></name><name><surname>Steidl</surname><given-names>U</given-names></name><name><surname>Manz</surname><given-names>MG</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal</article-title><source>Nature Cell Biology</source><volume>18</volume><fpage>607</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/ncb3346</pub-id><pub-id pub-id-type="pmid">27111842</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>L</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Kullberg</surname><given-names>B-J</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes</article-title><source>Cell Host &amp; Microbe</source><volume>12</volume><fpage>223</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.06.006</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Reusch</surname><given-names>N</given-names></name><name><surname>Paclik</surname><given-names>D</given-names></name><name><surname>Baßler</surname><given-names>K</given-names></name><name><surname>Schlickeiser</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Krämer</surname><given-names>B</given-names></name><name><surname>Krammer</surname><given-names>T</given-names></name><name><surname>Brumhard</surname><given-names>S</given-names></name><name><surname>Bonaguro</surname><given-names>L</given-names></name><name><surname>De Domenico</surname><given-names>E</given-names></name><name><surname>Wendisch</surname><given-names>D</given-names></name><name><surname>Grasshoff</surname><given-names>M</given-names></name><name><surname>Kapellos</surname><given-names>TS</given-names></name><name><surname>Beckstette</surname><given-names>M</given-names></name><name><surname>Pecht</surname><given-names>T</given-names></name><name><surname>Saglam</surname><given-names>A</given-names></name><name><surname>Dietrich</surname><given-names>O</given-names></name><name><surname>Mei</surname><given-names>HE</given-names></name><name><surname>Schulz</surname><given-names>AR</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Kunkel</surname><given-names>D</given-names></name><name><surname>Vafadarnejad</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>C-J</given-names></name><name><surname>Horne</surname><given-names>A</given-names></name><name><surname>Herbert</surname><given-names>M</given-names></name><name><surname>Drews</surname><given-names>A</given-names></name><name><surname>Thibeault</surname><given-names>C</given-names></name><name><surname>Pfeiffer</surname><given-names>M</given-names></name><name><surname>Hippenstiel</surname><given-names>S</given-names></name><name><surname>Hocke</surname><given-names>A</given-names></name><name><surname>Müller-Redetzky</surname><given-names>H</given-names></name><name><surname>Heim</surname><given-names>K-M</given-names></name><name><surname>Machleidt</surname><given-names>F</given-names></name><name><surname>Uhrig</surname><given-names>A</given-names></name><name><surname>Bosquillon de Jarcy</surname><given-names>L</given-names></name><name><surname>Jürgens</surname><given-names>L</given-names></name><name><surname>Stegemann</surname><given-names>M</given-names></name><name><surname>Glösenkamp</surname><given-names>CR</given-names></name><name><surname>Volk</surname><given-names>H-D</given-names></name><name><surname>Goffinet</surname><given-names>C</given-names></name><name><surname>Landthaler</surname><given-names>M</given-names></name><name><surname>Wyler</surname><given-names>E</given-names></name><name><surname>Georg</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Dang-Heine</surname><given-names>C</given-names></name><name><surname>Neuwinger</surname><given-names>N</given-names></name><name><surname>Kappert</surname><given-names>K</given-names></name><name><surname>Tauber</surname><given-names>R</given-names></name><name><surname>Corman</surname><given-names>V</given-names></name><name><surname>Raabe</surname><given-names>J</given-names></name><name><surname>Kaiser</surname><given-names>KM</given-names></name><name><surname>Vinh</surname><given-names>MT</given-names></name><name><surname>Rieke</surname><given-names>G</given-names></name><name><surname>Meisel</surname><given-names>C</given-names></name><name><surname>Ulas</surname><given-names>T</given-names></name><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Geffers</surname><given-names>R</given-names></name><name><surname>Witzenrath</surname><given-names>M</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Suttorp</surname><given-names>N</given-names></name><name><surname>von Kalle</surname><given-names>C</given-names></name><name><surname>Kurth</surname><given-names>F</given-names></name><name><surname>Händler</surname><given-names>K</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Aschenbrenner</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Nattermann</surname><given-names>J</given-names></name><name><surname>Sawitzki</surname><given-names>B</given-names></name><name><surname>Saliba</surname><given-names>A-E</given-names></name><name><surname>Sander</surname><given-names>LE</given-names></name><collab>Deutsche COVID-19 OMICS Initiative</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Severe COVID-19 is marked by a dysregulated myeloid cell compartment</article-title><source>Cell</source><volume>182</volume><fpage>1419</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.08.001</pub-id><pub-id pub-id-type="pmid">32810438</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AJP</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cytokine and cytokine receptor gene polymorphisms and their functionality</article-title><source>Cytokine &amp; Growth Factor Reviews</source><volume>20</volume><fpage>43</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2008.11.006</pub-id><pub-id pub-id-type="pmid">19038572</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>SJ</given-names></name><name><surname>Aguirre-Gamboa</surname><given-names>R</given-names></name><name><surname>de Bree</surname><given-names>LCJ</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>van der Velden</surname><given-names>W</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Khader</surname><given-names>S</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses</article-title><source>Immunity</source><volume>57</volume><fpage>2095</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2024.07.021</pub-id><pub-id pub-id-type="pmid">39153479</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swann</surname><given-names>JW</given-names></name><name><surname>Olson</surname><given-names>OC</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Made to order: emergency myelopoiesis and demand-adapted innate immune cell production</article-title><source>Nature Reviews. Immunology</source><volume>24</volume><fpage>596</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1038/s41577-024-00998-7</pub-id><pub-id pub-id-type="pmid">38467802</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vierbuchen</surname><given-names>T</given-names></name><name><surname>Ling</surname><given-names>E</given-names></name><name><surname>Cowley</surname><given-names>CJ</given-names></name><name><surname>Couch</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Harmin</surname><given-names>DA</given-names></name><name><surname>Roberts</surname><given-names>CWM</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>AP-1 transcription factors and the BAF complex mediate signal-dependent enhancer selection</article-title><source>Molecular Cell</source><volume>68</volume><fpage>1067</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.11.026</pub-id><pub-id pub-id-type="pmid">29272704</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuscan</surname><given-names>P</given-names></name><name><surname>Kischkel</surname><given-names>B</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Trained immunity: general and emerging concepts</article-title><source>Immunological Reviews</source><volume>323</volume><fpage>164</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1111/imr.13326</pub-id><pub-id pub-id-type="pmid">38551324</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>R</given-names></name><name><surname>Barlow</surname><given-names>C</given-names></name><name><surname>Lekstrom-Himes</surname><given-names>J</given-names></name><name><surname>Castilla</surname><given-names>LH</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name><name><surname>Eckhaus</surname><given-names>M</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><name><surname>Xanthopoulos</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein ɛ-deficient mice</article-title><source>PNAS</source><volume>94</volume><fpage>13187</fpage><lpage>13192</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.24.13187</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TNF-α coordinates hematopoietic stem cell survival and myeloid regeneration</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>357</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.05.019</pub-id><pub-id pub-id-type="pmid">31230859</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Spence</surname><given-names>JP</given-names></name><name><surname>Mostafavi</surname><given-names>H</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Bayesian estimation of gene constraint from an evolutionary model with gene features</article-title><source>Nature Genetics</source><volume>56</volume><fpage>1632</fpage><lpage>1643</lpage><pub-id pub-id-type="doi">10.1038/s41588-024-01820-9</pub-id><pub-id pub-id-type="pmid">38977852</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Nguyen-Jackson</surname><given-names>H</given-names></name><name><surname>Panopoulos</surname><given-names>AD</given-names></name><name><surname>Li</surname><given-names>HS</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Watowich</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>STAT3 controls myeloid progenitor growth during emergency granulopoiesis</article-title><source>Blood</source><volume>116</volume><fpage>2462</fpage><lpage>2471</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-12-259630</pub-id><pub-id pub-id-type="pmid">20581311</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>JL</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>O’Connell</surname><given-names>RM</given-names></name><name><surname>Mehta</surname><given-names>A</given-names></name><name><surname>DiLoreto</surname><given-names>R</given-names></name><name><surname>Heath</surname><given-names>JR</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>445</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.01.007</pub-id><pub-id pub-id-type="pmid">24561084</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Vartak</surname><given-names>SV</given-names></name><name><surname>Conte</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Garcia</surname><given-names>DA</given-names></name><name><surname>Stevens</surname><given-names>E</given-names></name><name><surname>Kyoung Jung</surname><given-names>S</given-names></name><name><surname>Kieffer-Kwon</surname><given-names>KR</given-names></name><name><surname>Vian</surname><given-names>L</given-names></name><name><surname>Stodola</surname><given-names>T</given-names></name><name><surname>Moris</surname><given-names>F</given-names></name><name><surname>Chopp</surname><given-names>L</given-names></name><name><surname>Preite</surname><given-names>S</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name><name><surname>Kulinski</surname><given-names>JM</given-names></name><name><surname>Olivera</surname><given-names>A</given-names></name><name><surname>Harly</surname><given-names>C</given-names></name><name><surname>Bhandoola</surname><given-names>A</given-names></name><name><surname>Heuston</surname><given-names>EF</given-names></name><name><surname>Bodine</surname><given-names>DM</given-names></name><name><surname>Urrutia</surname><given-names>R</given-names></name><name><surname>Upadhyaya</surname><given-names>A</given-names></name><name><surname>Weirauch</surname><given-names>MT</given-names></name><name><surname>Hager</surname><given-names>G</given-names></name><name><surname>Casellas</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>“Stripe” transcription factors provide accessibility to co-binding partners in mammalian genomes</article-title><source>Molecular Cell</source><volume>82</volume><fpage>3398</fpage><lpage>3411</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2022.06.029</pub-id><pub-id pub-id-type="pmid">35863348</pub-id></element-citation></ref></ref-list></back></article>